These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15357465)

  • 21. Results, rhetoric, and randomized trials: the case of donepezil.
    Gilstad JR; Finucane TE
    J Am Geriatr Soc; 2008 Aug; 56(8):1556-62. PubMed ID: 18662199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Limited efficacy of cholinesterase inhibitors in Alzheimer's dementia].
    Kornhuber J
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):553-4. PubMed ID: 15472777
    [No Abstract]   [Full Text] [Related]  

  • 24. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
    Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New drug treatment for Alzheimer's disease. Effects of drugs can be variable.
    Levy R
    BMJ; 1998 Oct; 317(7163):945. PubMed ID: 9841008
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy, efficiency and evidence -- studies on donepezil].
    Wallesch CW; Ebert AD
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778
    [No Abstract]   [Full Text] [Related]  

  • 28. Donepezil's effects remain uncertain.
    Royall DR
    J Am Geriatr Soc; 2004 May; 52(5):843-4; author reply 845-6. PubMed ID: 15086675
    [No Abstract]   [Full Text] [Related]  

  • 29. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
    Blacker D
    N Engl J Med; 2005 Jun; 352(23):2439-41. PubMed ID: 15829528
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of Alzheimer's disease: clinicians's lecture].
    Joray S; Ghika J; von Gunten A; Büla C; Gold G; Assal F
    Rev Med Suisse; 2006 Jan; 2(50):307. PubMed ID: 16503050
    [No Abstract]   [Full Text] [Related]  

  • 32. Dementia.
    Warner J; Butler R; Prabhakaran P
    Clin Evid; 2003 Jun; (9):1010-33. PubMed ID: 12967405
    [No Abstract]   [Full Text] [Related]  

  • 33. The amnestic prodrome of Alzheimer's disease.
    Hodges J
    Brain; 1998 Sep; 121 ( Pt 9)():1601-2. PubMed ID: 9762951
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drug treatment for Alzheimer's disease. Doctors want to offer more than sympathy.
    Dening T; Lawton C
    BMJ; 1998 Oct; 317(7163):945. PubMed ID: 9756823
    [No Abstract]   [Full Text] [Related]  

  • 36. Agitation in Alzheimer's disease: no to donepezil. Psycho-behavioural measures are better option.
    Prescrire Int; 2008 Oct; 17(97):212. PubMed ID: 19536942
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA is criticised for licensing high dose donepezil.
    Lenzer J
    BMJ; 2011 May; 342():d3270. PubMed ID: 21613347
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
    Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
    Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
    Asp E; Cloutier F; Fay S; Cook C; Robertson ML; Fisk J; Dei DW; Rockwood K
    Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.